Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature

Published:2024-08-23 Issue:9 Volume:32 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Iriarte Christopher,Yeh Jennifer E.,Alloo Allireza,Boull Christina,Carlberg Valerie M.,Coughlin Carrie C.,Lara-Corrales Irene,Levy Rebecca,Nguyen Cuong V.,Oza Vikash S.,Patel Anisha B.,Rotemberg Veronica,Shah Sonal D.,Zheng Lida,Miller Corinne H.,Hlobik Madeline,Daigneault Jaclyn,Choi Jennifer N.,Huang Jennifer T.,Vivar Karina L.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00520-024-08810-x.pdf

Reference127 articles.

1. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37–40

2. Lee S, Rauch J, Kolch W (2020) Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci 21(3):1102

3. Zhao Y, Adjei AA (2014) The clinical development of MEK inhibitors. Nat Rev Clin Oncol 11(7):385–400

4. Balagula Y, Huston KB et al (2011) Dermatologic side effects associated with the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886). Invest New Drugs 29:1114–1121

5. Shimano KA, Eng W, Adams DM (2022) How we approach the use of sirolimus and new agents: medical therapy to treat vascular anomalies. Pediatr Blood Cancer 69:e29603

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP